ARTICLE | Clinical News

GastroPanel regulatory update

September 8, 2014 7:00 AM UTC

Biohit said Chinese health associations The Chinese Society of Digestive Endoscopy and The Society of Ontological Endoscopy of Chinese Anti-Cancer Association issued a consensus clause recommending serum screening with Pepsinogen I and II, Gastrin-17 and Helicobacter pylori tests to diagnose early gastric cancer. The consensus was published in the Chinese Journal of Digestion, Chinese Journal of Gastroenterology and Gastro-Disease Journal, and will also be introduced at the Chinese National Gastroenterology meeting this month. Biohit's GastroPanel kit -- a non-invasive blood test that can diagnose H. pylori infection, and damage or dysfunction of the mucus membrane of the stomach -- consists of the 4 recommended tests and is already marketed in China. ...